5Lebovitz HE.D iffrentiating m embers of the th iazolid ined ioneclass:a focus on safety. D iabetes M etab Res Rev . 2002
6Iwumoto Y,Kosaka K,Kuzuya T,et a.l E ffects of troglitazone. Diabetes Care . 1996
7StumvollM,Haring HU.G litazones:clin ical effects ang molecu larm echan ism s. 4nn M ed . 2002
8Castle CK,Colca JR,M elch ior GW.L ipoprotein profile charac-terization of the KKA mouse,a rodentmodel of type II d iabetes,before and after treatm entw ith the insu lin sensitizing agent p iogli-tazone. Arteriosclerosis and Thrombosis . 1992
9Kraegen EW,,Jam es DE,Jenk ins D J,et a.l A potent in vivoeffects of ciglitazone on muscle insu lin-resistance induced by h ighfat fed ing in rats. m etabolism . 1989
